Download PDF
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Adherence to treatment with tofacitinib in patients with rheumatoid arthritis in daily clinical practice
Tatiana Barbich; Osvaldo Luis Cerda; Emilce Edith Schneeberger; Gustavo Citera;
Reumatol Clin. 2022;18:164-8
Do patients with axial spondyloarthritis with active disease suffer from greater disease burden and work impairment? Results from the International Map of Axial Spondyloarthritis (IMAS)
Marco Garrido-Cumbrera; Denis Poddubnyy; Fernando Sommerfleck; Christine Bundy; Souzi Makri; José Correa-Fernández; Shashank Akerkar; Jo Lowe; Elie Karam; Victoria Navarro-Compán;
Reumatol Clin. 2024;20:547-54
Development and feasibility of 4 checklists for the evaluation of comorbidity in patients with rheumatoid arthritis, axial spondyloarthritis and psoriatic arthritis: GECOAI Project
Santos Castañeda; Carlos González; Virginia Villaverde; Cristina Lajas Petisco; María Carmen Castro; Fernando Jirout; Juan Carlos Obaya; Juan Carlos Hermosa; Carmen Suárez; Silvia García; María Rodero; Leticia León; Amparo López Esteban; Milena Gobbo; Laly Alcaide; Juan Carlos Torre-Alonso;
Reumatol Clin. 2022;18:114-23